Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new site revision tag 'Revision: v3.4.2' and removal/update of prior system notices (including a government funding/operating status notice and 'Revision: v3.4.1'). These are administrative updates and do not modify study content or its presentation.
    Difference
    0.4%
    Check dated 2026-02-11T05:44:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a clinical study report synopsis, sponsor information (AbbVie), Helpful Links, and a site revision note (Revision: v3.4.1). Removed the previous revision (Revision: v3.4.0) and included a government funding notice for currency of information.
    Difference
    0.6%
    Check dated 2026-02-04T05:31:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T03:50:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor update: the page revision changed from v3.3.3 to v3.3.4; no other content or functionality appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:29:13.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Expanded and reorganized the Locations section to include prefecture-level locations (Aichi-ken, Chiba, Hokkaido, Mie-ken, Osaka, Shizuoka, Tokyo), with a revision note indicating v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T13:30:11.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publications are now described as automatically filled from PubMed and may not all relate to the study. The revision label changed from v3.2.0 to v3.3.2 and certain publication-related items (e.g., 'clinical study report synopsis', 'AbbVie', 'Helpful Links Provided by') were removed.
    Difference
    0.3%
    Check dated 2025-11-24T17:53:59.000Z thumbnail image

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.